Gary serves as Chief Compliance and Corporate Development Officer at Flora California, Inc. He has a passion for developing Cannabis products at the highest standard of quality so that its most therapeutic effects can be realized. His 25-year background in Pharmaceuticals and Medical Devices helps him to bring that scientific rigor to the Cannabis Industry. Gary is very active at both the State and Federal level as an advocate for policy reform/higher quality standards. Gary’s experience includes lengthy stints at both Eli Lilly and Pfizer in Clinical Development as well as Corporate Development, and several start-ups developing corporate and compliance strategies. He has a BS/BA from UC San Diego in Biochemistry/Psychology, an MS in Clinical Physiology from Indiana University, and an MBA from the University of Michigan.